OCT Europe: Small and mid-sized sponsors demand smart and reliable partnerships
At the OCT Europe meeting, experts discussed the challenges and strategies of small and mid-sized biopharma companies surrounding clinical trials.
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
Design Therapeutics reports positive outcomes from trial of DT-168 eye drops
New £1bn cancer research hub planned for South London
Tempus selects TIME Network for Phase I clinical trials
Immunic presses ahead with MS drug despite Phase II endpoint miss
Analysis
View More
Themes
View MoreIoT can help to reduce the burden of clinical trials on patients
IoT helps to decentralise clinical trials, allowing them to become increasingly patient-centric and diverse while providing pharmaceutical companies with a higher return on investment.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines